Ooops... Something went wrong while loading this page.
Stocktwits on MSN
Capricor or Sarepta: Two DMD stocks enter a high-stakes week – which one has more upside?
Capricor is preparing a February submission to the FDA for its DMD cell therapy Deramiocel, following a formal request for the full Phase 3 Hope-3 clinical study report. ・Koyfin expects Sarepta to ...
Stock market movers: futures dip in a holiday week as ZIM soars on a $4.2B buyout, biotechs rally on Phase 3 data, and WPM ...
Clinical Trials Arena on MSN
Compass stock heads north on psychedelic’s Phase III TRD success
Compass will now seek approval for COMP360, which could become the first classic psychedelic to gain the FDA’s blessing.
There are several ways investors can earn a return from a long position in a stock. One of the most tax-efficient is to let management reinvest profits internally to compound the share price over time ...
Novartis announced positive Phase III results from the RemIND trial showing that the oral BTK inhibitor remibrutinib achieved significantly higher complete response rates than placebo in three major ...
(PRESS RELEASE) BASEL, 18-Feb-2026 — / EuropaWire / — Roche has announced the appointment of Mark Dawson, M.D., Ph.D., as Head of Roche Pharma Research and Early Development (pRED), effective 1 May ...
Lehigh Valley snow totals increase as confidence grows in significant winter storm. Latest amounts and timing February 21, 2026 at 1:03 pm Top Stories TMC Lehigh Valley snow totals increase as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results